| Vol. 6.14 – 19 April, 2021 |
| |
|
|
| The authors described muscular dystrophy associated with pathogenic variants in JAG2 and suggested a disease mechanism related to Notch pathway dysfunction. [American Journal of Human Genetics] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| In vitro, relaxin stimulation of relaxin family peptide receptor 1 (RXFP1) – expressing cardiomyocytes induced downstream signaling resulting in PKA-specific phosphorylation of phospholamban, which was distinguishable from β-adrenergic activation. [Molecular Therapy] |
|
|
|
| circRNA regulated cardiomyocyte apoptosis and proliferation by acting as a miR-103-3p sponge and inducing increased expression of SNRK which could bind GSK3β to regulate its phosphorylated activity. [Cell Death Discovery] |
| |
|
|
| Investigators provided the first evidence that autologous gene repaired human muscle stem cells could be harnessed for cell replacement therapies of muscular dystrophies. [JCI Insight] |
|
|
|
| Using a BaCl2 induced damage model, researchers found that RNA toxicity led to decreased expression of PAX7, and decreased numbers of satellite cells, the stem cells of adult skeletal muscle . [Human Molecular Genetics] |
|
|
|
| Scientists suggest that valdecoxib alleviated insulin resistance through AMP-activated protein kinase/heat shock protein beta 1-mediated inhibition of inflammation and endoplasmic reticulum stress in skeletal muscle under hyperlipidemic conditions. [Biochemical Pharmacology] |
| |
|
|
| Both pharmacological focal adhesion kinase (FAK) and genetic FAK inhibition reduced S-phase kinase-associated protein 2 (Skp2) expression in Vascular smooth muscle cells (VSMCs) upon injury, which significantly reduced intimal hyperplasia through elevated expression of p27 and p21. [Cardiovascular Research] |
|
|
|
| Scientists investigated whether loss of SMC TGF-β signaling in mice alters aortic contractile-protein levels and aortic contractility. [Arteriosclerosis Thrombosis and Vascular Biology] |
|
|
|
| The authors showed that inhibition of C/EBP homologous protein (CHOP) might inhibit the proliferation and migration of vascular smooth muscle cells as well as reduce the levels of TC, TG, and LDL-C but increase the level of HDL-C through the tribbles homologue 33/microRNA-208/tissue inhibitor of metalloproteinases-3 (TIMP3) axis, thereby inhibiting the progression of atherosclerosis. [Cardiovascular Drugs and Therapy] |
|
|
|
| Researchers demonstrate that both GluN1 and GluN2 subunit mRNAs were expressed in human pulmonary artery. They found GluN1 and GluN2 (A–D) subunit proteins were expressed by human pulmonary artery smooth muscle cells in vitro and in vivo. [Scientific Reports] |
|
|
|
|
| Scientists discuss the relationship between muscle stem cells and motor neurons during Drosophila neuromuscular system development and adverse impact of affected muscle stem cell–motor neuron interactions in regenerating vertebrate muscle. [Cellular and Molecular Life Sciences] |
|
|
|
| The authors highlight both the key historical studies that underpin modern prostaglandin research in the heart, while concurrently presenting the latest findings related to how prostaglandin metabolism and signalling impact myocardial injury and repair. [American Journal of Physiology-Heart and Circulatory Physiology] |
|
|
|
|
| PTC Therapeutics, Inc. announced that results from Part II of the pivotal FIREFISH trial demonstrated that infants with type 1 spinal muscular atrophy treated with Evrysdiâ„¢ obtained increases in survival and sustained improvements in achieving key motor milestones, including head control, sitting, rolling over, and further developing towards acquiring the ability to stand, and walk. [PTC THerapeutics, Inc.] |
|
|
|
| Actimed Therapeutics Ltd., announced a license agreement for S-oxprenolol to Faraday Pharmaceuticals, Inc. S-oxprenolol is one of a new class of anabolic-catabolic transforming agents under development by Actimed. [Actimed Therapeutics Ltd.] |
|
|
|
|
| September 5 – 8, 2021 Exeter, England, United Kingdom |
|
|
|
|
|
| University of Michigan – Ann Arbor, Michigan, United States |
|
|
|
| Aspect Biosystems – Vancouver, British Columbia, Canada |
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| Mount Sinai Health System – New York, New York, United States |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
|